Elucidating the exact pharmacological mechanism of motion (MOA) of naturally transpiring compounds might be tough. Whilst Tarselli et al. (60) developed the very first de novo artificial pathway to conolidine and showcased that this naturally taking place compound efficiently suppresses responses to the two chemically induced and inflammation-deriv